Skip header and navigation

Refine By

70 records – page 1 of 7.

10 health stories that mattered: Mar. 3-7.

https://arctichealth.org/en/permalink/ahliterature104776
Source
CMAJ. 2014 Apr 15;186(7):E209
Publication Type
Article
Date
Apr-15-2014

Anophthalmia and microphthalmia in the Alberta Congenital Anomalies Surveillance System.

https://arctichealth.org/en/permalink/ahliterature175298
Source
Can J Ophthalmol. 2005 Feb;40(1):38-44
Publication Type
Article
Date
Feb-2005
Author
R Brian Lowry
Ruth Kohut
Barbara Sibbald
Jocelyn Rouleau
Author Affiliation
Alberta Congenital Anomalies Surveillance System, Health Surveillance, Alberta Health and Wellness, Calgary, Alta. Brian.Lowry@calgaryhealthregion.ca
Source
Can J Ophthalmol. 2005 Feb;40(1):38-44
Date
Feb-2005
Language
English
Publication Type
Article
Keywords
Alberta - epidemiology
Anophthalmos - epidemiology - genetics
Birth weight
Cluster analysis
Gestational Age
Health Surveys
Humans
Infant, Newborn
Microphthalmos - epidemiology - genetics
Ophthalmology - statistics & numerical data
Population Surveillance
Prevalence
Abstract
A higher than expected rate of anophthalmia/microphthalmia (A/M) for 1999 was noted in both the Alberta Congenital Anomalies Surveillance System (ACASS) and the Canadian Congenital Anomalies Surveillance System (CCASS). Since this increase was at variance with the previous 19 years, we performed a review to determine whether the increase was true and, if so, the possible explanation.
We reviewed the records of the cases of A/M in the ACASS together with the accompanying attachments (e.g., consultant, autopsy and chromosome reports) for 1991-2001. In addition, we contacted all 91 registered ophthalmologists in Alberta. Letters were also written to the Edmonton and Calgary offices of the Canadian National Institute for the Blind (CNIB).
Sixty cases of A/M were ascertained over the study period. Of the 88 active ophthalmologists in the province, 21 (24%) replied, but no new cases were ascertained from this source. No replies were received from the CNIB. We constructed five categories of clinical phenotypes for the 60 cases: 20 had a chromosomal etiology, 13 had a recognized syndrome or association, 16 had extraocular malformations, 5 had other eye anomalies, and 6 had A/M only. Pregnancy terminations were not included. The higher rate in 1999 was mainly due to cases with a chromosomal etiology or a recognized syndrome or association. There was no indication that a teratogen was causing a cluster of A/M cases, as our annual rates were comparable to those for other jurisdictions not only in Canada but also in other countries.
Our review confirmed that the rate of A/M in Alberta in 1999 was high but that the increase was mainly due to five cases of trisomy 13 together with one case associated with a syndrome (Meckel-Gruber). Our findings provide reassurance that there was no environmental cause of clustering of anophthalmia or microphthalmia. This review demonstrates the importance of ongoing population-based surveillance in providing baseline birth prevalence rates for evaluating trends and clusters.
Notes
Erratum In: Can J Ophthalmol. 2006 Apr;41(2):232
PubMed ID
15825528 View in PubMed
Less detail

Arsenic and pressure-treated wood: the argument moves to the playground.

https://arctichealth.org/en/permalink/ahliterature191882
Source
CMAJ. 2002 Jan 8;166(1):79
Publication Type
Article
Date
Jan-8-2002
Author
Barbara Sibbald
Source
CMAJ. 2002 Jan 8;166(1):79
Date
Jan-8-2002
Language
English
Publication Type
Article
Keywords
Arsenic - analysis
Canada
Child
Environmental monitoring
Humans
Soil Pollutants - analysis
Wood
PubMed ID
11800256 View in PubMed
Less detail

BC takes ax to budget of a health system "in danger".

https://arctichealth.org/en/permalink/ahliterature191220
Source
CMAJ. 2002 Feb 19;166(4):492
Publication Type
Article
Date
Feb-19-2002

Bringing a research base to psychiatry.

https://arctichealth.org/en/permalink/ahliterature157372
Source
CMAJ. 2008 May 6;178(10):1257-60
Publication Type
Article
Date
May-6-2008
Author
Miriam Shuchman
Paul C Hébert
Rajendra Kale
Barbara Sibbald
Ken Flegel
Noni MacDonald
Source
CMAJ. 2008 May 6;178(10):1257-60
Date
May-6-2008
Language
English
French
Publication Type
Article
Keywords
Advisory Committees
Biomedical research
Canada
Depressive Disorder - drug therapy
Evidence-Based Medicine
Humans
Mental Health Services - standards
Psychiatry
Randomized Controlled Trials as Topic
Serotonin Uptake Inhibitors - therapeutic use
Notes
Cites: N Engl J Med. 2005 Sep 22;353(12):1209-2316172203
Cites: Am J Psychiatry. 2006 Feb;163(2):185-9416449469
Cites: Arch Gen Psychiatry. 2006 Oct;63(10):1079-8717015810
Cites: N Engl J Med. 2006 Oct 12;355(15):1525-3817035647
Cites: Am J Psychiatry. 2006 Nov;163(11):1905-1717074942
Cites: Am J Psychiatry. 2006 Dec;163(12):2080-917151158
Cites: Am J Psychiatry. 2007 Mar;164(3):526-7; author reply 527-817329483
Cites: N Engl J Med. 2007 Apr 26;356(17):1711-2217392295
Cites: Can J Psychiatry. 2007 Jun;52(6):363-817696022
Cites: Am J Psychiatry. 2007 Oct;164(10):1462-417898331
Cites: Arch Gen Psychiatry. 2007 Oct;64(10):1132-4317909125
Cites: Br J Psychiatry. 2008 Mar;192(3):161-318310570
Cites: JAMA. 2008 Feb 27;299(8):901-1318314433
Cites: Lancet. 2008 Mar 29;371(9618):1085-9718374841
Cites: CMAJ. 2008 May 6;178(10):1293-30118458261
Cites: CMAJ. 2008 May 6;178(10):1313-518458263
Cites: Am J Psychiatry. 2006 Mar;163(3):54916513889
Cites: BMJ. 2002 Aug 24;325(7361):44112193365
Cites: Science. 2003 Oct 3;302(5642):63-7214526066
Cites: Am J Psychiatry. 2005 May;162(5):836-4615863782
Cites: Am J Psychiatry. 2006 Jan;163(1):5-716390879
Comment On: CMAJ. 2008 May 6;178(10):1293-30118458261
PubMed ID
18458250 View in PubMed
Less detail

Building Namibia's HIV and mental health services.

https://arctichealth.org/en/permalink/ahliterature167704
Source
CMAJ. 2006 Aug 29;175(5):463
Publication Type
Article
Date
Aug-29-2006

70 records – page 1 of 7.